Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
The Pharmaceutical Marketing Group
The Pharmaceutical Marketing Group
PROFESSIONAL EDITION
The largest community of pharma leaders
Subscribe to Our News!
Facebook
Instagram
Linkedin
Pinterest
Twitter
Search
Home
FEATURED
Featured Report
FEATURED WEBINAR
MEET OUR FEATURED WRITERS
NATALIE YEADON
TOMASO SALANITRI
NEWSLETTERS
SUBSCRIBE NOW
NEWS
Make Webinars works for your business
Call For Featured Writers
ABOUT US
Our Agency
Our Services
Our Resources
More
Webinars
2019 Authors
Featured Authors
Must Read
Newsletters
Webinars
Webinars
Novartis, LEO Pharma & MSD discuss what HCPs want – and how you can give it to them
Dear Colleague Long gone are the days of knocking on doors with a smile and a promise – today, success with HCPs depends on how...
Admin
-
September 25, 2019
0
Read more
The Power of Habit – Creating Positive Feedback Loops in Healthcare
Did you know that almost half of all decisions are based on habits? However, that does not mean that we cannot change our habits (and...
Admin
-
September 20, 2019
0
Read more
Webinars
SMM for Pharma: 3 Top Strategies & Fresh Tactics for Quick Wins
Jodie Green and Ilya Nejdanov, will share 3 top strategies and tactics for quick wins, including: Budget: The #1 tactic you can use right now...
Admin
-
August 20, 2019
0
Read more
1
2
Page 2 of 2
Recent Articles
Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines
Editor´s Pick
March 6, 2021
Covid-19: MedinCell Publishes an Extensive Ivermectin Safety Expert Analysis
Industry News
March 6, 2021
EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients
Industry News
March 6, 2021
U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy
Regulatory Affairs
March 6, 2021
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir
Clinical Trials
March 6, 2021
Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic...
Industry News
March 5, 2021
Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan
Editor´s Pick
March 5, 2021
Can-Fite Enrolls First Patient in Phase II COVID-19 Study Under FDA Protocol
Clinical Trials
March 5, 2021
BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Second- or Third-line Non-Small Cell Lung Cancer
Regulatory Affairs
March 5, 2021
Ridgeback Biotherapeutics Announces Publication of Phase 1 Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses...
Clinical Trials
March 4, 2021
GC Pharma Finalises Agreement With Moderna and the Government of the Republic of Korea for COVID-19 Vaccines Distribution
Editor´s Pick
March 4, 2021
Merck Begins Tender Offer to Acquire Pandion Therapeutics
Industry News
March 4, 2021
Talaris Therapeutics Appoints Mary Kay Fenton as Chief Financial Officer
Look Who’s On the Move!
March 4, 2021
New Research Reveals More CROs Taking Action to Meet Urgent Need for Faster Clinical Trials
Clinical Trials
March 4, 2021
Apnimed Strengthens Management Team with Addition of Leading Sleep Medicine Expert, David P. White, M.D.
Look Who’s On the Move!
March 4, 2021
